No Data
No Data
Changshan Biochemical Gets Approval From Niger for Thrombosis Drug
Hebei Changshan Biochemical Pharmaceutical (300255.SZ): Enoxaparin Sodium Injection obtained the drug registration certificate of Niger.
Geelonghui October 17th | Hebei Changshan Biochemical Pharmaceutical (300255.SZ) announced that the company recently received a notification that its pharmaceutical enoxaparin sodium injection obtained a drug registration certificate issued by the Nigerian National Agency for Food and Drug Administration. Enoxaparin sodium injection is used to prevent venous thromboembolic diseases (prevent venous thrombosis formation), especially thrombosis formation related to orthopedic or general surgery; treat deep vein thrombosis that has already formed, with or without pulmonary embolism, clinical symptoms not severe, not including pulmonary embolism requiring surgical or thrombolytic treatment; used in combination with aspirin to treat unstable angina and non-Q wave myocardial infarction.
Investors further inquired about the progress of the GLP-1 new drug review. Hebei Changshan Biochemical Pharmaceutical responded that the registration inspection has been completed and the approval time cannot be estimated. Directly focus on the earnings
①At today's earnings conference, investors repeatedly inquired about the progress and approval time of the GLP-1 drug Aibonapeptide injection, with management stating that it is unpredictable; ②Management revealed that the on-site verification and registration inspection of Aibonapeptide have been completed, and clinical trials for weight loss indications have not yet been initiated; ③Regarding the decline in performance compared to multiple quarters, management stated that they will speed up going global to restore the profitability of the heparin business.
Changshan Biochemical Pharmaceutical's Unit Gets EU GMP Certificate
Is Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Using Too Much Debt?
Hebei Changshan Biochemical Pharmaceutical (300255.SZ): The production facility of Enoxaparin Sodium Injection has passed the European Union GMP certification for the first time.
GeLonghui September 20th | Hebei Changshan Biochemical Pharmaceutical (300255.SZ) announced that the company recently received a "Drug GMP Certificate" issued by the Republic of Croatia Agency For Medicinal Products And Medical Devices based on the relevant regulations of the European Medicines Agency. Ennogen liver
No Data
No Data